---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000124"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T07:03:26.720243+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst beats Q3 rev midpoint; raises FY rev guidance; Adj. EBITDA positive

## Summary
- Total revenue $73.8M (+8% YoY); tech revenue $46.0M (+4%), pro services $27.8M (+14%).
- Net loss $22.0M vs $45.7M loss YoY (improved 52%); loss from ops $24.6M vs $45.7M.
- Adjusted EBITDA $2.0M vs ($4.6M) loss a year ago; Q3 beat midpoint on both rev and EBITDA.
- Raised FY2023 revenue guidance range; reiterated FY2023 Adjusted EBITDA guidance.
- Full Q3 results and conference call rescheduled to November 2, 2023.

## SEC filing metadata
- accession: 0001636422-23-000124
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/0001636422-23-000124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/hcat-20231027.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000124
- JSON: https://secwatch.observer/filing/0001636422-23-000124.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000124.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported the quarter ended September 30, 2023 results: revenue $73.8 million. Guidance raised.
  - Period: the quarter ended September 30, 2023
  - Revenue: $73.8 million
  - Guidance: raised
  - Result: preliminary results
  source text: timing. See below for quarterly conference call details. “For the third quarter of 2023, I am pleased by our strong preliminary financial results, including total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, with these results beating the mid-point of our quarterly guidance on each metric. Additionally, we are grateful to be in a position to raise
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/0001636422-23-000124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.